Cargando…
SelSA-1, a novel HDAC inhibitor demonstrates enhanced chemotherapeutic potential by redox modulation
Colorectal cancer (CRC) is a multistep disorder resulting from genetic and epigenetic genome changes. It is the third most common malignancy in developed nations accounting for roughly 600,000 deaths annually. Persistent gut inflammation, as observed in inflammatory bowel disease (IBD), is a key ris...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250299/ https://www.ncbi.nlm.nih.gov/pubmed/37291249 http://dx.doi.org/10.1038/s41598-023-36555-w |